Literature DB >> 25673041

Delivery Blood Pressure and Other First Pregnancy Risk Factors in Relation to Hypertensive Disorders in Second Pregnancies.

Nansi S Boghossian1, Paul S Albert2, Pauline Mendola3, Katherine L Grantz3, Edwina Yeung4.   

Abstract

BACKGROUND: First pregnancy characteristics and blood pressure (BP) measures may be associated with second pregnancy hypertensive disorder risk. We examined the association between first pregnancy risk factors and second pregnancy hypertensive disorders.
METHODS: Electronic medical records of nulliparas (n = 26,787) delivering at least twice in Utah (2002-2010) were used. Polychotomous logistic regression models estimated the association of first pregnancy risk factors with second pregnancy hypertensive disorders (gestational hypertension, preeclampsia, or chronic hypertension) stratified by first pregnancy hypertensive status and adjusted for second characteristics.
RESULTS: Among normotensive women in their first pregnancy, preterm birth (<34 weeks) and elevated BP at delivery admission in the first pregnancy increased odds of all incident hypertensive disorders in the second. Even borderline admission BP (either systolic or diastolic BP: 130-139 or 85-89 mm Hg, respectively) was associated with a doubling of hypertensive disorder risk in a subsequent pregnancy. First pregnancy BP was also associated with recurrence risks for hypertensive disorders, but the relation was stronger for women with gestational hypertension in their first pregnancy with more than 2-fold elevated risk across all BP categories (odds ratios range: 2.32-12.6). However, the majority of women (75%) with a hypertensive disorder in the first pregnancy do not repeat this outcome in the second pregnancy.
CONCLUSION: Delivery admission BP of a first pregnancy was strongly related to hypertensive disorder incidence and recurrence in the subsequent pregnancy. Although crude, these measures may prove useful as a predictor of long-term maternal health and future pregnancy risk. © Published by Oxford University Press on behalf of American Journal of Hypertension Ltd 2015. This work is written by (a) US Government employees(s) and is in the public domain in the US.

Entities:  

Keywords:  blood pressure; chronic hypertension; gestational hypertension; hypertension; preeclampsia.

Mesh:

Year:  2015        PMID: 25673041      PMCID: PMC4542849          DOI: 10.1093/ajh/hpv001

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  26 in total

Review 1.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.

Authors:  Kirsten Duckitt; Deborah Harrington
Journal:  BMJ       Date:  2005-03-02

2.  Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births.

Authors:  Dorothea Mostello; Dorina Kallogjeri; Rachata Tungsiripat; Terry Leet
Journal:  Am J Obstet Gynecol       Date:  2008-02-15       Impact factor: 8.661

3.  Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study.

Authors:  H S Ros; S Cnattingius; L Lipworth
Journal:  Am J Epidemiol       Date:  1998-06-01       Impact factor: 4.897

4.  ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

Authors: 
Journal:  Obstet Gynecol       Date:  2002-01       Impact factor: 7.661

5.  Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group.

Authors:  B M Sibai; M Ewell; R J Levine; M A Klebanoff; J Esterlitz; P M Catalano; R L Goldenberg; G Joffe
Journal:  Am J Obstet Gynecol       Date:  1997-11       Impact factor: 8.661

6.  Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?

Authors:  José Villar; Guillermo Carroli; Daniel Wojdyla; Edgardo Abalos; Daniel Giordano; Hassan Ba'aqeel; Ubaldo Farnot; Per Bergsjø; Leiv Bakketeig; Pisake Lumbiganon; Liana Campodónico; Yagob Al-Mazrou; Marshall Lindheimer; Michael Kramer
Journal:  Am J Obstet Gynecol       Date:  2006-04       Impact factor: 8.661

7.  Can we predict recurrence of pre-eclampsia or gestational hypertension?

Authors:  M A Brown; C Mackenzie; W Dunsmuir; L Roberts; K Ikin; J Matthews; G Mangos; G Davis
Journal:  BJOG       Date:  2007-06-14       Impact factor: 6.531

8.  Recurrence of hypertensive disorder in second pregnancy.

Authors:  Sigrun Hjartardottir; Björn G Leifsson; Reynir T Geirsson; Valgerdur Steinthorsdottir
Journal:  Am J Obstet Gynecol       Date:  2006-04       Impact factor: 8.661

9.  Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study.

Authors:  Elisabeth Balstad Magnussen; Lars Johan Vatten; Tom Ivar Lund-Nilsen; Kjell Asmund Salvesen; George Davey Smith; Pål Richard Romundstad
Journal:  BMJ       Date:  2007-11-01

10.  Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study.

Authors:  Sonia Hernández-Díaz; Sengwee Toh; Sven Cnattingius
Journal:  BMJ       Date:  2009-06-18
View more
  3 in total

1.  Interpregnancy weight change and adverse maternal outcomes: a retrospective cohort study.

Authors:  Chelsea Lynes; Alexander C McLain; Edwina H Yeung; Paul Albert; Jihong Liu; Nansi S Boghossian
Journal:  Ann Epidemiol       Date:  2017-09-21       Impact factor: 3.797

2.  Histopathological lesions and exposure to Plasmodium falciparum infections in the placenta increases the risk of preeclampsia among pregnant women.

Authors:  Dorotheah Obiri; Isaac Joe Erskine; Daniel Oduro; Kwadwo Asamoah Kusi; Jones Amponsah; Ben Adu Gyan; Kwame Adu-Bonsaffoh; Michael Fokuo Ofori
Journal:  Sci Rep       Date:  2020-05-19       Impact factor: 4.379

Review 3.  A global view of hypertensive disorders and diabetes mellitus during pregnancy.

Authors:  Li Jiang; Kun Tang; Laura A Magee; Peter von Dadelszen; Alec Ekeroma; Xuan Li; Enyao Zhang; Zulfiqar A Bhutta
Journal:  Nat Rev Endocrinol       Date:  2022-09-15       Impact factor: 47.564

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.